Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia

Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

112 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia trial results

Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

NCT07354074

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 24 locations
View Trial Details
Recruiting

Asciminib Roll-over Study

NCT04877522

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • Michigan Med University of Michigan Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University Portland, Oregon, United States
  • Texas Oncology Dallas, Texas, United States
View all 85 locations
View Trial Details
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions
ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Methods of T Cell Depletion Trial (MoTD)

NCT04888741

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations
  • University Hospital of Wales Cardiff, Wales, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
View all 17 locations
View Trial Details

Related conditions